YD Biopharma

At YD Biopharma, we are committed to revolutionizing the future of healthcare by harnessing cutting-edge biotechnology and precision medicine. Our mission is to provide advanced solutions for some of the most pressing medical challenges, including cancer detection, regenerative medicine, and personalized therapies. Founded by Dr. Ethan Shen, YD Biopharma has become a pioneer in developing innovative liquid biopsy technologies for early cancer detection and Limbal Stem Cell Exosome Therapy for dry eye disease. We leverage proprietary scientific research and advanced cellular therapies to offer patients safer, more effective treatment options that improve outcomes and quality of life. Our expertise spans multiple therapeutic areas, including oncology, immunotherapy, and regenerative medicine. With a strong global presence, we collaborate with leading pharmaceutical companies and research institutions to push the boundaries of medical science and bring groundbreaking treatments to market. At YD Biopharma, we believe that science has the power to change lives. Our team of experts is dedicated to translating innovative research into real-world solutions that address unmet medical needs and shape the future of healthcare. Join us on our journey to redefine medicine and improve lives through scientific innovation and collaboration.